Association between proton pump inhibitors and the risk of hepatocellular carcinoma

YHJ Shao, TS Chan, K Tsai… - Alimentary pharmacology & …, 2018 - Wiley Online Library
Background Proton pump inhibitor (PPI) use has been reported to be associated with liver
damage and might possibly be carcinogenic. Aims We examined whether long‐term PPI use …

[PDF][PDF] Association between proton pump inhibitors and the risk of hepatocellular carcinoma

YHJ Shao, TS Chan, K Tsai, SY Wu - researchgate.net
Background: Proton pump inhibitor (PPI) use has been reported to be associated with liver
damage and might possibly be carcinogenic. Aims: We examined whether long-term PPI …

Association between proton pump inhibitors and the risk of hepatocellular carcinoma.

YHJ Shao, TS Chan, K Tsai, SY Wu - 2018 - cabidigitallibrary.org
Background: Proton pump inhibitor (PPI) use has been reported to be associated with liver
damage and might possibly be carcinogenic. Aims: We examined whether long-term PPI …

Association between proton pump inhibitors and the risk of hepatocellular carcinoma

YHJ Shao, TS Chan, K Tsai… - Alimentary …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Proton pump inhibitor (PPI) use has been reported to be associated with liver
damage and might possibly be carcinogenic. Aims We examined whether long-term PPI use …

Association between proton pump inhibitors and the risk of hepatocellular carcinoma

YHJ Shao, TS Chan, K Tsai, SY Wu - Alimentary Pharmacology and …, 2018 - hub.tmu.edu.tw
BACKGROUND: Proton pump inhibitor (PPI) use has been reported to be associated with
liver damage and might possibly be carcinogenic. AIMS: We examined whether long-term …

Association between proton pump inhibitors and the risk of hepatocellular carcinoma.

YJ Shao, TS Chan, K Tsai, SY Wu - Alimentary Pharmacology & …, 2018 - europepmc.org
BACKGROUND: Proton pump inhibitor (PPI) use has been reported to be associated with
liver damage and might possibly be carcinogenic. AIMS: We examined whether long-term …

Association between proton pump inhibitors and the risk of hepatocellular carcinoma

YHJ Shao, TS Chan, K Tsai, SY Wu - Alimentary Pharmacology and …, 2018 - hub.tmu.edu.tw
Background: Proton pump inhibitor (PPI) use has been reported to be associated with liver
damage and might possibly be carcinogenic. Aims: We examined whether long-term PPI …